4-Bromo-3-(trifluoromethoxy)pyridine hydrobromide

97%

Reagent Code: #130618
fingerprint
CAS Number 2665660-83-1

science Other reagents with same CAS 2665660-83-1

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 322.91 g/mol
Formula C₆H₄Br₂F₃NO
badge Registry Numbers
MDL Number MFCD34178761
inventory_2 Storage & Handling
Storage 2-8°C, Sealed, Inert Gas

description Product Description

Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of agrochemicals and bioactive molecules. Its halogenated pyridine structure makes it valuable in cross-coupling reactions, such as Suzuki or Buchwald-Hartwig aminations, enabling the construction of complex heterocyclic systems. The presence of both bromine and trifluoromethoxy groups allows for selective functionalization, facilitating the optimization of pharmacokinetic properties in drug discovery programs. Commonly employed in research settings for designing kinase inhibitors and receptor modulators.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 250mg
10-20 days ฿20,880.00
inventory 100mg
10-20 days ฿13,990.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
4-Bromo-3-(trifluoromethoxy)pyridine hydrobromide
No image available

Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of agrochemicals and bioactive molecules. Its halogenated pyridine structure makes it valuable in cross-coupling reactions, such as Suzuki or Buchwald-Hartwig aminations, enabling the construction of complex heterocyclic systems. The presence of both bromine and trifluoromethoxy groups allows for selective functionalization, facilitating the optimization of pharmacokinetic properties in drug discovery programs

Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of agrochemicals and bioactive molecules. Its halogenated pyridine structure makes it valuable in cross-coupling reactions, such as Suzuki or Buchwald-Hartwig aminations, enabling the construction of complex heterocyclic systems. The presence of both bromine and trifluoromethoxy groups allows for selective functionalization, facilitating the optimization of pharmacokinetic properties in drug discovery programs. Commonly employed in research settings for designing kinase inhibitors and receptor modulators.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...